enquiry@technavio.com

Allergy Treatment Market by Allergy Type, by Treatment and Geography: Analysis, Size, Growth, Trends, and Forecast, 2024-2028

Allergy Treatment Market by Allergy Type, by Treatment and Geography: Analysis, Size, Growth, Trends, and Forecast, 2024-2028

Home Upcoming Report Allergy Treatment Market

Market Size

info_image

The allergy treatment market is driven by the prevalence of conditions such as asthma, allergies, and immune system sensitivities. Common triggers include animal dander, dust mites, pollen, weeds, and mold, collectively referred to as aeroallergens. Food allergies, particularly to peanuts, are also a common concern. This means there is high demand for products that enable allergy diagnosis, treatment, and management. This market is segmented by allergy type (such as food allergies and skin allergies), by the type of treatment (medication or immunotherapy), and by region, including North America, Europe, APAC, South America, and the Middle East and Africa. This report also analyzes key competitors in the allergy treatment market, such as Allergy Therapeutics, F. Hoffmann-La Roche, and GlaxoSmithKline.

Technavio’s in-depth industry report offers historical data as well as a comprehensive market forecast. It analyzes the current state of the allergy treatment market and provides detailed predictions on its performance over the coming years. It examines key factors such as market drivers, challenges, and key emerging trends, as well as the global competitive landscape. Also included is a breakdown of the types of products available on the market, along with their market shares and future prospects.

Market Report Highlights

Allergy Type
  • Asthma
  • Eye Allergies
  • Food Allergies
  • Rhinitis
  • Skin Allergies
  • Others
Treatment
  • Anti-Allergy Drugs
  • Immunotherapy
Regional Landscape
  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa
Key Companies Profiled
  • ALK-Abello AS
  • Allergy Therapeutics plc
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Sanofi SA

Market Report Insights

  • Precise evaluation of the market’s size, including historical data and a forecast of market performance from 2024 to 2028
  • Qualitative and quantitative analysis of the current market scenario and future prospects, allowing clients to make informed business decisions
  • In-depth analysis of the drivers and challenges that will impact the growth of the market between 2024 and 2028
  • Predictions about upcoming trends and changes in consumer behavior
  • A thorough industry analysis of the competitive landscape and detailed information on key companies in the market, including factors such as market positioning and product offerings
  • Region-by-region analysis of market growth and opportunities across North America, Europe, APAC, South America, and the Middle East and Africa

Market Segmentation

The allergy treatment market is segmented according to allergy type, treatment, and region. Technavio’s industry report provides actionable market insights on each segment, including market share and growth forecasts.

Allergy Type Segmentation

  • Asthma
  • Eye Allergies
  • Food Allergies
  • Rhinitis
  • Skin Allergies
  • Others

Treatment Segmentation

  • Anti-Allergy Drugs
  • Immunotherapy

Regional Analysis

Different parts of the world will have different demands, supply chain logistics, legal nuances, and other factors to take into consideration when entering a new market. Technavio’s allergy treatment market research helps facilitate strategic business decisions by providing a historical and focused look at regional markets, including market trends, drivers, and challenges as well as predictions for regional market sizes and growth. North America is a leading region in the global market due to the substantial amount of allergy research taking place there, as well as high spending on healthcare.

Geographical Segmentation:

  • North America
    • Segmentation by allergy
    • Segmentation by treatment
  • Europe
    • Segmentation by allergy
    • Segmentation by treatment
  • APAC
    • Segmentation by allergy
    • Segmentation by treatment
  • South America
    • Segmentation by allergy
    • Segmentation by treatment
  • The Middle East and Africa
    • Segmentation by allergy
    • Segmentation by treatment

info_region

Competitive Landscape

This report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies in order to help clients improve their market positions. It also provides a detailed analysis of the upcoming allergy treatment market trends and challenges and how they will influence market growth, designed to help companies create effective strategies to make the most of the global market.

Companies leading the global allergy treatment market include:

  • ALK-Abello AS
  • Allergy Therapeutics plc
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Sanofi SA

info_keycomapnies

Market Dynamics

In order to make informed business decisions and strategies, it’s important to be informed of the many factors impacting the market. What is driving growth in the market and how does that influence new product releases? What challenges are increasing risk for a specific course of action or in a specific market? What will the key trends be over the next several years and what is the best way to take advantage of them? The answers to these questions help companies to evaluate business approaches and develop growth strategies.

Immunotherapy, along with traditional medications like steroids and antihistamines, remains a cornerstone of allergy treatment. Subcutaneous Immunotherapy (SCIT) has shown efficacy in desensitizing patients, and recent advancements such as Palforzia offer hope to those with peanut allergies.

Environmental factors, including pollution, contribute to the rise in allergies, exacerbating symptoms such as eye allergies, skin allergies, rhinitis, and hay fever. Symptoms range from itching, sneezing, teary eyes, and a stuffy nose to vomiting, diarrhea, and respiratory problems, sometimes culminating in severe reactions like anaphylaxis, particularly in response to bee stings or peanuts.

The allergy treatment market faces challenges related to healthcare spending, especially given the high cost of medications and therapies. Moreover, the shortage of skilled professionals and lack of adequate healthcare infrastructure pose barriers to effective treatment delivery, particularly in regions with high prevalence rates. But despite regulatory hurdles and the high cost associated with drug approvals and launches, the market continues to witness innovation. Bio-similar products are emerging as potential alternatives, offering more accessible options for patients.

FAQ

Are there any emerging treatments in the allergy treatment market?

Emerging treatments include novel immunotherapy approaches, personalized medicine using genetic profiling, and advancements in biologic therapies targeting different pathways in the immune system.

How is the allergy treatment market impacted by regulatory considerations?

Regulatory agencies oversee the safety and efficacy of allergy medications and therapies. They set guidelines for clinical trials, approval processes, labeling requirements, and post-marketing surveillance to ensure patient safety.

What are the future prospects for the allergy treatment market?

Future prospects include advancements in precision medicine tailored to individual allergies, greater accessibility to effective treatments, improved patient outcomes through targeted therapies, and ongoing research into allergy prevention strategies.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Exhibit 14: Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 16: Chart on North America: Year-over-year growth 2023-2028 (%)
    • Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)

4 Historic Market Size

  • 4.1 Dietary supplements market in North America 2018 - 2022
    • Exhibit 18: Historic Market Size – Data Table on dietary supplements market in north America 2018 - 2022 ($ billion)
  • 4.2 Distribution Channel Segment Analysis 2018 - 2022
    • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
  • 4.3 Product Segment Analysis 2018 - 2022
    • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
    • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Exhibit 22: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Exhibit 25: Threat of new entrants – Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Exhibit 26: Threat of substitutes – Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Exhibit 27: Threat of rivalry – Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
    • Exhibit 29: Chart on Distribution Channel - Market share 2023-2028 (%)
    • Exhibit 30: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
    • Exhibit 31: Chart on Comparison by Distribution Channel
    • Exhibit 32: Data Table on Comparison by Distribution Channel
  • 6.3 Offline - Market size and forecast 2023-2028
    • Exhibit 33: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 34: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 35: Chart on Offline - Year-over-year growth 2023-2028 (%)
    • Exhibit 36: Data Table on Offline - Year-over-year growth 2023-2028 (%)
  • 6.4 Online - Market size and forecast 2023-2028
    • Exhibit 37: Chart on Online - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 38: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 39: Chart on Online - Year-over-year growth 2023-2028 (%)
    • Exhibit 40: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Distribution Channel
    • Exhibit 41: Market opportunity by Distribution Channel ($ billion)
    • Exhibit 42: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product

  • 7.1 Market segments
    • Exhibit 43: Chart on Product - Market share 2023-2028 (%)
    • Exhibit 44: Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
    • Exhibit 45: Chart on Comparison by Product
    • Exhibit 46: Data Table on Comparison by Product
  • 7.7 Others - Market size and forecast 2023-2028
    • Exhibit 63: Chart on Others - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 64: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 65: Chart on Others - Year-over-year growth 2023-2028 (%)
    • Exhibit 66: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.8 Market opportunity by Product
    • Exhibit 67: Market opportunity by Product ($ billion)
    • Exhibit 68: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Exhibit 70: Chart on Market share by geography - 2023-2028 (%)
    • Exhibit 71: Data Table on Market share by geography - 2023-2028 (%)
  • 9.2 Geographic comparison
    • Exhibit 72: Chart on Geographic comparison
    • Exhibit 73: Data Table on Geographic comparison
  • 9.6 Market opportunity by geography
    • Exhibit 74: Market opportunity by geography ($ billion)
    • Exhibit 75: Data Table on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Exhibit 76: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
    • Exhibit 77: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
    • Exhibit 78: Overview on factors of disruption
  • 11.4 Industry risks
    • Exhibit 79: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
    • Exhibit 80: Vendors covered
  • 12.2 Market positioning of vendors
    • Exhibit 81: Matrix on vendor position and classification
  • 13 Appendix
  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Exhibit 82: Inclusions checklist
    • Exhibit 83: Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Exhibit 84: Currency conversion rates for US$
  • 13.4 Research methodology
    • Exhibit 85: Research methodology
    • Exhibit 86: Validation techniques employed for market sizing
    • Exhibit 87: Information sources
  • 13.5 List of abbreviations
    • Exhibit 88: List of abbreviations